Tarsus Uses Veterinary Drug To Target Unserved Ocular Disease

With success on multiple endpoints in its first pivotal trial of lotilaner in Demodex blepharitis, Tarsus is working to bring the veterinary antiparasitic drug to market in multiple human indications.